β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats

Abstract

β-sitosterol (SIT), the most abundant bioactive component of vegetable oil and other plants, is a highly potent antidiabetic drug. Our previous studies show that SIT controls hyperglycemia and insulin resistance by activating insulin receptor and glucose transporter 4 (GLUT-4) in the adipocytes of obesity induced type 2 diabetic rats. The current research was undertaken to investigate if SIT could also exert its antidiabetic effects by circumventing adipocyte induced inflammation, a key driving factor for insulin resistance in obese individuals. Effective dose of SIT (20 mg/kg b.wt) was administered orally for 30 days to high fat diet and sucrose induced type-2 diabetic rats. Metformin, the conventionally used antidiabetic drug was used as a positive control. Interestingly, SIT treatment restores the elevated serum levels of proinflammatory cytokines including leptin, resistin, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) to normalcy and increases anti-inflammatory adipocytokines including adiponectin in type 2 diabetic rats. Furthermore, SIT decreases sterol regulatory element binding protein-1c (SREBP-1c) and enhances Peroxisome Proliferator–activated receptor-γ (PPAR-γ) gene expression in adipocytes of diabetic rats. The gene and protein expression of c-Jun-N-terminal kinase-1 (JNK1), inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) and nuclear factor kappa B (NF-κB) were also significantly attenuated in SIT treated groups. More importantly, SIT acts very effectively as metformin to circumvent inflammation and insulin resistance in diabetic rats. Our results clearly show that SIT inhibits obesity induced insulin resistance by ameliorating the inflammatory events in the adipose tissue through the downregulation of IKKβ/NF-κB and c-Jun-N-terminal kinase (JNK) signaling pathway.

Molecular docking and GC-MS data for the inhibition of RAD51 expression by a compound from Clerodendrum inerme L.

“…Traditional plant-based medicines still put forth a great deal of importance to people living in developing countries leading to the discovery of new drug candidates [ 16 ]. Various studies reported that these computational techniques could strongly support and help the design of novel, more potent inhibitors by revealing the mechanism of drug-receptor interaction [ 17 ]. Computational biology and bioinformatics have not only the potential to speed up the drug discovery process thus reduces the cost but it also facilitates and speed up the drug designing process [18].…”

Molecular docking analysis of penta galloyl glucose with the bcl-2 family of anti-apoptotic targets

“…Water molecules and all non-standard residues have been eliminated from the basic structure. After that, all missing hydrogens and kollman charges were added to the system, and the finished protein receptor was saved as a pdbqt file and inserted immediately into PyRx's workspace folders [ 13 ].…”

Molecular docking analysis of bioactive compounds from Mollugo cerviana (L.) SER with DHFR for antifungal activity

“…Ligands were prepared using MGL tools by adding hydrogen atom to check the valencies of the heavy atoms. Ligand was minimized by computing gasteiger charges and saved in PDBQT [ 10 ].…”